6 results match your criteria: "Thomas E. Starzl Transplantation Institute University of Pittsburgh[Affiliation]"
Estimation of Sensitization Status in Renal Transplant Recipients by Assessing Indirect Pathway CD4 + T Cell Response to Donor Cell-pulsed Dendritic Cell.
Transplantation
May 2023
Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Japan.
Background: Generation of donor-specific human leukocyte antigen antibody (DSA) via indirect allorecognition is detrimental to long-term survival of transplant organs. The detection of such immune responses would make it possible to define patients with high risk of sensitization. In this study, we established a novel method for evaluating indirect allorecognition to assess sensitization in kidney transplant recipients.
View Article and Find Full Text PDFBackground: The COVID-19 pandemic affected the volume and epidemiology of pediatric emergency department (ED) visits. We aimed to determine the rate of associated complications for 16 high-risk conditions in a Michigan statewide network of academic and community EDs during the pandemic.
Methods: We conducted a cross-sectional study of pediatric ED visits among a network of 5 Michigan health systems during the pre-pandemic (March 1, 2019-March 10, 2020) and pandemic (March 11, 2020-March 31, 2021) periods.
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.
Liver Transpl
May 2021
School of Medicine and Division of Gastroenterology and Hepatology Stanford University Stanford CA Division of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA Department of Medicine Stanford University Stanford CA Department of Surgery, Multi-Organ Transplantation Stanford University School of Medicine Stanford CA Dumont-UCLA (University of California, Los Angeles) Transplant and Liver Cancer Centers, Department of Surgery David Geffen School of Medicine at UCLA Los Angeles CA Recanati/Miller Transplantation Institute Mount Sinai Medical Center New York NY Annette C. and Harold C. Simmons Transplant Institute Baylor University Medical Center Dallas TX Department of Surgery, Division of Intra-Abdominal Transplantation Loyola University of Chicago, Stritch School of Medicine Maywood IL Department of Transplantation Mayo Clinic Jacksonville FL Division of Gastroenterology and Hepatology Penn Transplant InstituteUniversity of Pennsylvania Philadelphia PA Center for Liver Disease and Transplantation Columbia University Medical Center, NY Presbyterian Hospital New York NY Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery Weill Cornell Medical College New York NY Thomas E. Starzl Transplantation Institute University of Pittsburgh Medical Center Pittsburgh PA Section of TransplantationDepartment of Surgery Washington University in St. Louis St. Louis MO Cleveland Clinic Foundation Cleveland OH Division of Transplant SurgeryDepartment of Surgery University of Colorado School of Medicine Denver CO Division of Transplant Surgery Massachusetts General HospitalHarvard Medical School Boston MA Sherrie & Alan Conover Center for Liver Disease & Transplantation Houston Methodist Hospital Houston TX Department of Surgery University of Nebraska Medical Center Omaha NE Division of Transplantation and Hepatobiliary SurgeryDepartment of Surgery University of California, San Diego San Diego CA Department of Surgery Duke University Medical Center Durham NC Division of Transplant SurgeryDepartment of Surgery Medical College of Wisconsin Milwaukee WI Department of Surgery Baylor College of Medicine Houston TX Section of Hepatobiliary and Transplant Surgery University of Louisville School of Medicine Louisville KY Medstar Georgetown Transplant Institute Georgetown University Washington DC.
The incidence of hepatocellular carcinoma (HCC) is growing in the United States, especially among the elderly. Older patients are increasingly receiving transplants as a result of HCC, but the impact of advancing age on long-term posttransplant outcomes is not clear. To study this, we used data from the US Multicenter HCC Transplant Consortium of 4980 patients.
View Article and Find Full Text PDFIntroducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates.
Liver Transpl
April 2021
Division of Gastroenterology, Hepatology and Nutrition Thomas E. Starzl Transplantation Institute, Pittsburgh Liver Research Center, University of Pittsburgh School of Medicine Pittsburgh PA Liver Transplantation Program University of Pittsburgh Medical Center Pittsburgh PA Healthy Lifestyle Institute University of Pittsburgh School of Education Pittsburgh PA Department of Surgery, Thomas E. Starzl Transplantation Institute University of Pittsburgh School of Medicine Pittsburgh PA Donald W. Reynolds Institute on Aging University of Arkansas for Medical Sciences Little Rock AR Division of Gastroenterology and Hepatology Stanford University Palo Alto CA.
Preserved physical function is key for successful liver transplantation (LT); however, prehabilitation strategies are underdeveloped. We created a smartphone application (app), EL-FIT (Exercise and Liver FITness), to facilitate exercise training in end-stage liver disease (ESLD). In this feasibility study, we tested EL-FIT app usage and the accuracy of physical activity data transfer and obtained feedback from initial users.
View Article and Find Full Text PDFComparison of proliferative capacity of genetically-engineered pig and human corneal endothelial cells.
Ophthalmic Res
September 2013
Department of Surgery, Thomas E. Starzl Transplantation Institute University of Pittsburgh, Pittsburgh, PA 15261, USA.
Purpose: The possibility of providing cultured corneal endothelial cells (CECs) for clinical transplantation has gained much attention. However, the worldwide need for human (h) donor corneas far exceeds supply. The pig (p) might provide an alternative source.
View Article and Find Full Text PDFEndotoxin treatment causes an upregulation of the endothelin system in the liver: amelioration of increased portal resistance by endothelin receptor antagonism.
J Gastroenterol Hepatol
January 2001
Thomas E Starzl Transplantation Institute University of Pittsburgh and Veterans Administration Medical Center Pittsburgh, Pennsylvania 15213, USA.
Background: Mechanisms underlying hepatic microcirculatory failure during endotoxemia are incompletely understood. Because endothelin-1 (ET-1) has been implicated in endotoxin-induced liver injury, we investigated the hepatic ET-1 system in endotoxin-treated rats.
Methods: Rats were treated with endotoxin (Escherichia coli lipopolysaccharide; 3 mg/kg, i.